Cargando…
Molecular-targeted therapy toward precision medicine for gastrointestinal caner: Current progress and challenges
Gastrointestinal (GI) cancer remains the deadliest cancer in the world. The current standard treatment for GI cancer focuses on 5-fluorouracil-based chemotherapeutic regimens and surgery, and molecular-targeted therapy is expected to be a more effective and less toxic therapeutic strategy for GI can...
Autores principales: | Matsuoka, Tasuku, Yashiro, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131909/ https://www.ncbi.nlm.nih.gov/pubmed/34040699 http://dx.doi.org/10.4251/wjgo.v13.i5.366 |
Ejemplares similares
-
Precision medicine for gastrointestinal cancer: Recent progress and future perspective
por: Matsuoka, Tasuku, et al.
Publicado: (2020) -
Current status and perspectives of genetic testing in gastrointestinal cancer (Review)
por: Matsuoka, Tasuku, et al.
Publicado: (2023) -
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
por: Chaudry, M A, et al.
Publicado: (2007) -
The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers
por: Matsuoka, Tasuku, et al.
Publicado: (2023) -
Lower urinary tract dysfunction in pediatrics progress to kidney disease in adolescents: Toward precision medicine in treatment
por: Wishahi, Mohamed
Publicado: (2021)